25 Healthcare Stocks Moving In Monday's Pre-Market Session

Gainers

• Enlivex Therapeutics, Inc. ENLV stock surged 27.5% to $11.88 during Monday's pre-market session. The most recent rating by H.C. Wainwright, on January 09, is at Buy, with a price target of $20.00.
• China Jo-Jo Drugstores, Inc. CJJD shares surged 20.1% to $2.15.
• Lianluo Smart, Inc. LLIT stock moved upwards by 15.7% to $0.76.
• Cleveland BioLabs, Inc. CBLI stock surged 13.1% to $2.25.
• Novavax, Inc. NVAX stock increased by 11.1% to $8.58.
• Inovio Pharmaceuticals, Inc. INO stock rose 11.1% to $4.16. The most recent rating by PiperJaffray, on January 03, is at Overweight, with a price target of $8.00.
• Tocagen, Inc. TOCA stock surged 10.5% to $2.10.
• Co-Diagnostics, Inc. CODX shares rose 8.8% to $3.32. The most recent rating by HC Wainwright & Co., on February 24, is at Buy, with a price target of $4.00.
• Correvio Pharma, Inc. CORV stock surged 7.0% to $0.31. According to the most recent rating by H.C. Wainwright, on December 11, the current rating is at Neutral.
• Allied Healthcare Prods, Inc. AHPI stock increased by 6.1% to $2.61.

Losers

• Ritter Pharmaceuticals, Inc. RTTR shares decreased by 8.2% to $0.21 during Monday's pre-market session.
• Trillium Therapeutics, Inc. TRIL shares declined 8.1% to $3.84.
• Galapagos, Inc. GLPG shares decreased by 7.6% to $253.22. The most recent rating by HC Wainwright & Co., on February 24, is at Buy, with a price target of $302.00.
• DBV Technologies, Inc. DBVT stock decreased by 7.5% to $9.18. The most recent rating by Stifel, on January 09, is at Buy, with a price target of $18.00.
• Viveve Medical, Inc. VIVE shares plummeted 7.4% to $1.38. According to the most recent rating by Ladenburg Thalmann, on December 03, the current rating is at Buy.
• Cronos Group, Inc. CRON stock declined 6.8% to $6.66.
• Schrodinger, Inc. SDGR shares declined 6.4% to $46.80.
• Aurora Cannabis, Inc. ACB stock declined 6.3% to $1.56. The most recent rating by Piper Sandler, on January 10, is at Underweight, with a price target of $1.00.
• Genprex, Inc. GNPX stock plummeted 5.2% to $5.05.
• Onconova Therapeutics, Inc. ONTX stock fell 4.9% to $0.50.
• MorphoSys, Inc. MOR shares decreased by 4.4% to $29.54.
• Danaher, Inc. DHR shares declined 4.4% to $154.70. The most recent rating by Needham, on February 03, is at Buy, with a price target of $187.00.
• Rockwell Medical, Inc. RMTI stock declined 4.4% to $3.06.
• Alcon, Inc. ALC shares declined 4.3% to $60.77. The most recent rating by Morgan Stanley, on December 17, is at Overweight, with a price target of $70.00.
• OPKO Health, Inc. OPK shares declined 4.3% to $1.56.